IRadimed Statistics Share Statistics IRadimed has 12.72M
shares outstanding. The number of shares has increased by 0.36%
in one year.
Shares Outstanding 12.72M Shares Change (YoY) 0.36% Shares Change (QoQ) 0% Owned by Institutions (%) 54.75% Shares Floating 8.02M Failed to Deliver (FTD) Shares 740 FTD / Avg. Volume 1.42%
Short Selling Information The latest short interest is 227.16K, so 1.79% of the outstanding
shares have been sold short.
Short Interest 227.16K Short % of Shares Out 1.79% Short % of Float 2.83% Short Ratio (days to cover) 3.92
Valuation Ratios The PE ratio is 36.23 and the forward
PE ratio is 33.86.
IRadimed's PEG ratio is
3.08.
PE Ratio 36.23 Forward PE 33.86 PS Ratio 9.51 Forward PS 9.9 PB Ratio 8.03 P/FCF Ratio 39.55 PEG Ratio 3.08
Financial Ratio History Enterprise Valuation IRadimed has an Enterprise Value (EV) of 644.78M.
EV / Sales 8.8 EV / EBITDA 28.3 EV / EBIT 25.16 EV / FCF 36.59
Financial Position The company has a current ratio of 8.84,
with a Debt / Equity ratio of 0.
Current Ratio 8.84 Quick Ratio 7.62 Debt / Equity 0 Debt / EBITDA 0.01 Debt / FCF 0.01 Interest Coverage 0
Financial Efficiency Return on Equity is 22.15% and Return on Invested Capital is 19.31%.
Return on Equity 22.15% Return on Assets 19.56% Return on Invested Capital 19.31% Revenue Per Employee $457.76K Profits Per Employee $120.21K Employee Count 160 Asset Turnover 0.74 Inventory Turnover 1.62
Taxes Income Tax 5.04M Effective Tax Rate 20.77%
Stock Price Statistics The stock price has increased by 59.07% in the
last 52 weeks. The beta is 0.95, so IRadimed's
price volatility has been higher than the market average.
Beta 0.95 52-Week Price Change 59.07% 50-Day Moving Average 60.11 200-Day Moving Average 55.66 Relative Strength Index (RSI) 74.02 Average Volume (20 Days) 52,111
Income Statement In the last 12 months, IRadimed had revenue of 73.24M
and earned 19.23M
in profits. Earnings per share was 1.52.
Revenue 73.24M Gross Profit 56.35M Operating Income 21.96M Net Income 19.23M EBITDA 22.78M EBIT 21.96M Earnings Per Share (EPS) 1.52
Full Income Statement Balance Sheet The company has 52.23M in cash and 154.69K in
debt, giving a net cash position of 52.08M.
Cash & Cash Equivalents 52.23M Total Debt 154.69K Net Cash 52.08M Retained Earnings 56.79M Total Assets 101.73M Working Capital 66.66M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 25.62M
and capital expenditures -8.01M, giving a free cash flow of 17.62M.
Operating Cash Flow 25.62M Capital Expenditures -8.01M Free Cash Flow 17.62M FCF Per Share 1.39
Full Cash Flow Statement Margins Gross margin is 76.94%, with operating and profit margins of 29.99% and 26.26%.
Gross Margin 76.94% Operating Margin 29.99% Pretax Margin 33.14% Profit Margin 26.26% EBITDA Margin 31.11% EBIT Margin 29.99% FCF Margin 24.06%
Dividends & Yields IRMD pays an annual dividend of $0.81,
which amounts to a dividend yield of 0.94%.
Dividend Per Share $0.81 Dividend Yield 0.94% Dividend Growth (YoY) 13.33% Payout Ratio 50.31% Earnings Yield 2.76% FCF Yield 2.53%
Dividend Details Analyst Forecast The average price target for IRMD is $72,
which is 2.9% higher than the current price. The consensus rating is "Strong Buy".
Price Target $72 Price Target Difference 2.9% Analyst Consensus Strong Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $38 Lynch Upside -45.71% Graham Number 15.3 Graham Upside -78.14%
Scores Altman Z-Score 48.55 Piotroski F-Score 5
